CAS No.:154-41-6
Name: DL-Norephedrine hydrochloride
Details Introduction
TOXICITY DATA with REFERENCE：
| 1. |
orl-rat LD50:1490 mg/kg |
TXAPA9 Toxicology and Applied Pharmacology. 18 (1971),185. | ||
| 2. |
ipr-rat LD50:160 mg/kg |
JPETAB Journal of Pharmacology and Experimental Therapeutics. 86 (1946),284. | ||
| 3. |
scu-rat LDLo:80 mg/kg |
JPETAB Journal of Pharmacology and Experimental Therapeutics. 71 (1941),62. | ||
| 4. |
orl-mus LD50:150 mg/kg |
THERAP Therapie. 20 (1965),297. | ||
| 5. |
ipr-mus LD50:428 mg/kg |
JPETAB Journal of Pharmacology and Experimental Therapeutics. 92 (1948),207. | ||
| 6. |
scu-mus LD50:600 mg/kg |
JPETAB Journal of Pharmacology and Experimental Therapeutics. 86 (1946),280. | ||
| 7. |
ivn-mus LDLo:275 mg/kg |
QJPPAL Quarterly Journal of Pharmacy and Pharmacology. 9 (1936),203. | ||
| 8. |
scu-rbt LD50:255 mg/kg |
JPETAB Journal of Pharmacology and Experimental Therapeutics. 86 (1946),284. | ||
| 9. |
ivn-rbt LD50:50 mg/kg |
JPETAB Journal of Pharmacology and Experimental Therapeutics. 86 (1946),284. | ||
| 10. |
ims-rbt LD50:320 mg/kg |
JPETAB Journal of Pharmacology and Experimental Therapeutics. 86 (1946) |
Consensus Reports：Reported in EPA TSCA Inventory.
SAFETY PROFILE：
Poison by ingestion, subcutaneous, intravenous, intraperitoneal, and intramuscular routes. An experimental teratogen. When heated to decomposition it emits very toxic fumes of HCl and NOx. Used as a raw material in cold and diet tablets.
Hazard Codes:Xn
Xn:Harmful
Risk Statements
Harmful if swallowed.
Safety Statements
S22:Do not breathe dust .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) .
RIDADR:UN 2811
WGK Germany:3
RTECS:DN4200000
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione